CAN
DTIL icon

Cetera Advisor Networks’s Precision BioSciences DTIL Stock Holding History

Cetera Advisor Networks’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3
Closed -$1K – 1668
2020
Q2 		$1K Buy
+3
New +$657 ﹤0.01% 3321

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's DTIL Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Precision BioSciences (DTIL) in Q3 2020, closing a stake of 3 shares — an estimated $1K sold.

Cetera Advisor Networks first reported a position in DTIL in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 116 funds tracked by Wall St. Rank hold DTIL as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Precision BioSciences position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 3 Precision BioSciences shares in Q3 2020, an estimated $1K.
  • Cetera Advisor Networks first reported a position in Precision BioSciences in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Precision BioSciences position peaked at $1K in Q2 2020.
  • 116 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.